In our study, we decided to determine the presence of MT1A (rs11076161), MT2A (rs28366003) and MT1L (rs10636) polymorphisms among the studied patients as research on the influence of the selected polymorphisms on the risk of developing endometrial cancer has not yet been conducted. The gene discussed is MT1L; the disease is endometrial cancer.